HomeCONGRESS

CONGRESS

View Category
Day 1

PARADIGM-HF: New family of drugs for chronic heart failure

Therapy in heart failure has been to focus the neurohormonal pathways such as the renin-angiotensin-aldosterone system. Natriuretic...
solaci -
Learn More
Day 4

INOVARE VALVE: Braile prosthesis for the treatment of transapical aortic stenosis

Diego Gaia2014-09-17
solaci -
Learn More
Day 4

TAVR: Study comparing cardiac magnetic resonance versus transthoracic echocardiography to assess and quantify aortic regurgitation in patients undergoing TAVI

Henrique Ribeiro2014-09-17
solaci -
Learn More
Day 4

EVERBIO II: Bio-absorbable stent Absorb versus everolimus-eluting or biolimus stents

The new generation drug-eluting everolimus or biolimus stents have proved superior to the first generation. However, neo...
solaci -
Learn More
Day 4

EXCITE ISR: Excimer laser versus balloon angioplasty for stent restenosis of the superficial femoral

This multicenter, prospective, randomized trial compared the Excimer laser atherectomy (Excimer Laser Atherectomy = ELA, Spectranetics, Inc.)...
solaci -
Learn More
Day 3

DESTINY TRIAL: Stent de hastes finas com polímero eluidor de sirolimus

Pedro Lemos2014-09-16
solaci -
Learn More
Day 3

OPTIMIZE: 3 months versus 12 months of dual anti-aggregation with zotarolimus-eluting stents

The current recommendation for dual anti-aggregation post-DES implantation is 12 months. However, the ideal length for specific...
solaci -
Learn More
Day 4

PRIMA: Closure of patent foramen ovale in patients with migraine with aura refractory

It is hypothesized that the presence of a right-left shunt can trigger migraine attacks. The aim of...
solaci -
Learn More